Faced with a growing surge of new cases in Melbourne, Australia’s  has granted provisional approval to Gilead Sciences’ ( $GILD ) #remdesivir ("Veklury") as the first #treatment option for #COVID-19.

$GVAX $RGEN $SRNE $LLY $PFE $SAN $ATRA $VBIV $VXRT https://t.co/sGKyPyEPwi